InvestorsHub Logo
Followers 66
Posts 6963
Boards Moderated 0
Alias Born 10/06/2010

Re: A deleted message

Tuesday, 04/13/2021 7:20:05 AM

Tuesday, April 13, 2021 7:20:05 AM

Post# of 13962
Here is what I found

In October 2019, Alexion entered into an asset purchase agreement with Immune Pharma to acquire an anti eotaxin-1 antibody for the development in inflammatory diseases. The agreement is pending completion due to bankruptcy proceedings, which are expected to conclude by the first quarter of 2020.

https://www.immunepharma.com/why-the-bertilimumab-bullous-pemphigoid-trial-is-so-important/

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.